Lightyear Capital to sell Therapy Brands to KKR
We advised Lightyear Capital on the sale
Davis Polk is advising Lightyear Capital LLC in connection with the acquisition of Therapy Brands by KKR from investment funds affiliated with Lightyear, Oak HC/FT and Greater Sum Ventures. The transaction is expected to close in the second quarter of 2021. Financial terms of the transaction were not disclosed.
Founded in 2000, Lightyear Capital is a financial services-focused private equity firm based in New York. Therapy Brands provides practice management, integrated patient payments, revenue cycle management, patient engagement, tele-health and data management solutions for mental and behavioral health practices to support their clinical, administrative and billing needs. KKR is a leading global investment firm that offers alternative asset management and capital markets and insurance solutions.
The Davis Polk corporate team includes partners Michael Davis and Harold Birnbaum and associates Arthur M.T. Burke and Lucas Wozny. The tax team includes partner David H. Schnabel and counsel Ethan R. Goldman. Partner Pritesh P. Shah is providing intellectual property advice. Partner Adam Kaminsky is providing executive compensation advice. The finance team includes partner J.W. Perry. The antitrust and competition team includes partner Jesse Solomon. Members of the Davis Polk team are based in the New York and Washington DC offices.